Antimicrobial resistance poses a huge problem in healthcare, undermining modern medicine. This could lead to common infections becoming deadly diseases. The experience of Covid-19 demonstrates that governments everywhere need access to interdisciplinary expertise to tackle infectious disease and AMR. Warwick has deep expertise in microbiology, drug discovery, epidemiology, public health, behavioural science, close links to industry and global connectivity: this puts Warwick at the forefront of developing new therapeutic strategies and training the next generation of AMR leaders.